Search | Clinical Trials Finder

ClinicalTrials.gov public records Last synced Sep 26, 2026, 1:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–14 of 14 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Intervention: sumatriptan succinate/naproxen sodium Clear all

Conditions: Migraine Disorders
Interventions: sumatriptan succinate/naproxen sodium, placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 34
States / cities: Mesa, Arizona • Little Rock, Arkansas • Fair Oaks, California + 31 more

Conditions: Migraine Disorders
Interventions: Combination Product (sumatriptan succinate / naproxen sodium), RELPAX(eletriptan) 40mg Tablet; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Migraine Disorders
Interventions: sumatriptan succinate/naproxen sodium, placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 623 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 52
States / cities: Anniston, Alabama • Tuscaloosa, Alabama • Mesa, Arizona + 48 more

Conditions: Migraine Disorders
Interventions: Combination Tablet of Treximet (sumatriptan/naproxen sodium); Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 12 Years to 17 Years
Enrollment: 656 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 77
States / cities: Gilbert, Arizona • Phoenix, Arizona • Jonesboro, Arkansas + 72 more

Conditions: Migraine, Migraine Disorders
Interventions: sumatriptan succinate/naproxen sodium; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 351 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 35
States / cities: Chandler, Arizona • Irvine, California • Redondo Beach, California + 30 more

Conditions: Migraine Disorders, Migraine, Acute
Interventions: TREXIMET®, Butalbital-containing Combination Medications (BCM), placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 375 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 107
States / cities: Chandler, Arizona • Gilbert, Arizona • Litchfield Park, Arizona + 94 more

Conditions: Migraine Disorders
Interventions: Combination Product (sumatriptan succinate / naproxen sodium), Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 173 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 26
States / cities: Fresno, California • Newport Beach, California • Santa Monica, California + 23 more

Conditions: Migraine Disorders, Migraine
Interventions: sumatriptan succinate/naproxen sodium, placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 646 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 50
States / cities: Chandler, Arizona • Phoenix, Arizona • Little Rock, Arkansas + 45 more

Conditions: Migraine, Without Aura
Interventions: sumatriptan succinate / naproxen sodium, Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 679 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 70
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Anaheim, California + 58 more

Conditions: Migraine Disorders
Interventions: TREXIMA™, IMITREX® (4mg), IMITREX® (6mg), IMITREX Tablet 100mg; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Tacoma, Washington

Conditions: Migraine
Interventions: sumatriptan succinate 85 mg/naproxen sodium 500 mg (Treximet); Drug
Lead sponsor: Cady, Roger, M.D.; Individual
Eligibility: 18 Years to 65 Years
Enrollment: 147 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 8
States / cities: San Francisco, California • Kalamazoo, Michigan • Springfield, Missouri + 5 more

Conditions: Migraine Headache, Cognitive Impairment
Interventions: Treximet, Migraine rescue medication of choice; Drug
Lead sponsor: Neurological Research Center; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Bennington, Vermont

Conditions: Migraine Disorders
Interventions: Placebo, Combination Product (sumatriptan succinate/naproxen sodium); Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 169 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 28
States / cities: Jasper, Alabama • Oceanside, California • San Francisco, California + 25 more

Conditions: Migraine Disorders
Interventions: Sumatriptan and Naproxen Sodium, Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 12 Years to 17 Years
Enrollment: 589 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 79
States / cities: Gilbert, Arizona • Litchfield Park, Arizona • Phoenix, Arizona + 71 more

Search by objective public record fields.

Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea

TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine

Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks

Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents

Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)

TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults

A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)

Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks

TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)

An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate)

"Completeness of Response" Following Treatment With Treximet™ for Migraine

Treximet in Acute Migraine Headache: Assessing Cognitive Function

A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)

Migraine Study in Adolescent Patients